Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9305)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2014 (publication date) through Nov 29, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Gómez-Hurtado I, Such J, Sanz Y, Francés R. Gut microbiota-related complications in cirrhosis. World J Gastroenterol 2014; 20(42): 15624-15631 [PMID: 25400446 DOI: 10.3748/wjg.v20.i42.15624] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i42/15624.htm |
| Number | Citing Articles |
| 1 |
Vera Odintsova, Natalia Klimenko, Alexander Tyakht, Olesya Volokh, Vladimir Popov, Dmitry Alexeev, Yulia Berezhnaya. Yogurt fortified with vitamins and probiotics impacts the frequency of upper respiratory tract infections but not gut microbiome: A multicenter double-blind placebo controlled randomized study. Journal of Functional Foods 2021; 83: 104572 doi: 10.1016/j.jff.2021.104572
|
| 2 |
Michał Grąt, Karolina M. Wronka, Zbigniew Lewandowski, Karolina Grąt, Maciej Krasnodębski, Jan Stypułkowski, Wacław Hołówko, Łukasz Masior, Irena Kosińska, Michał Wasilewicz, Joanna Raszeja-Wyszomirska, Sławomir Rejowski, Emil Bik, Waldemar Patkowski, Marek Krawczyk. Effects of continuous use of probiotics before liver transplantation: A randomized, double-blind, placebo-controlled trial. Clinical Nutrition 2017; 36(6): 1530 doi: 10.1016/j.clnu.2017.04.021
|
| 3 |
Valeria Maccauro, Carlo Airola, Francesco Santopaolo, Antonio Gasbarrini, Francesca Romana Ponziani, Maurizio Pompili. Gut Microbiota and Infectious Complications in Advanced Chronic Liver Disease: Focus on Spontaneous Bacterial Peritonitis. Life 2023; 13(4): 991 doi: 10.3390/life13040991
|
| 4 |
Petrus R. de Jong, José M. González-Navajas, Nicolaas J. G. Jansen. The digestive tract as the origin of systemic inflammation. Critical Care 2016; 20(1) doi: 10.1186/s13054-016-1458-3
|
| 5 |
Roman Maslennikov, Aliya Alieva, Elena Poluektova, Yury Zharikov, Andrey Suslov, Yana Letyagina, Ekaterina Vasileva, Anna Levshina, Evgenii Kozlov, Vladimir Ivashkin. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World Journal of Gastroenterology 2023; 29(27): 4236-4251 doi: 10.3748/wjg.v29.i27.4236
Abstract(649) |
Core Tip(579) |
Full Article(HTML)(3334)
|
Full Article with Cover (PDF)-2077K(111)
|
Full Article (Word)-351K(59)
|
Audio-395K(9)
|
Peer-Review Report-291K(64)
|
Answering Reviewers-97K(75)
|
Full Article (PDF)-967K(303)
|
Full Article (XML)-396K(79)
|
Times Cited (12)
|
Total Visits (7279)
|
Open
|
| 6 |
Toru Shizuma. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World Journal of Hepatology 2018; 10(2): 254-266 doi: 10.4254/wjh.v10.i2.254
|
| 7 |
Cristina Maria Marginean, Denisa Pirscoveanu, Mihaela Popescu, Corina Maria Vasile, Anca Oana Docea, Radu Mitruț, Iulia Cristina Mărginean, George Alexandru Iacob, Dan Mihai Firu, Paul Mitruț. Challenges in Diagnosis and Therapeutic Approach of Acute on Chronic Liver Failure—A Review of Current Evidence. Biomedicines 2023; 11(7): 1840 doi: 10.3390/biomedicines11071840
|
| 8 |
|
| 9 |
Qin Ning, Tao Chen, Guiqiang Wang, Dong Xu, Yanyan Yu, Qing Mao, Taisheng Li, Lanjuan Li, Jun Li, Xiaoju Lu, Jiabin Li, Zhiwei Li, Wenhong Zhang, Yonghong Xiao, Qinghua Meng, Yuqiang Mi, Jia Shang, Yunsong Yu, Yingren Zhao, Caiyan Zhao, Hong Zhao, Jianrong Huang, Jie Peng, Hong Tang, Xiaoping Tang, Jinhua Hu, Bijie Hu, Wei Guo, Bo Zheng, Baiyi Chen, Yuexin Zhang, Jia Wei, Jifang Sheng, Zhi Chen, Minggui Wang, Qing Xie, Yuming Wang, Fu-Sheng Wang, Jinlin Hou, Zhongping Duan, Lai Wei, Jidong Jia. Expert Consensus on Diagnosis and Treatment of End-Stage Liver Disease Complicated with Infections. Infectious Diseases & Immunity 2022; 2(3): 168 doi: 10.1097/ID9.0000000000000055
|
| 10 |
Xuemei Tao, Ning Wang, Wenxin Qin. Gut Microbiota and Hepatocellular Carcinoma. Gastrointestinal Tumors 2015; 2(1): 33 doi: 10.1159/000380895
|
| 11 |
Mattia Paratore, Francesco Santopaolo, Giovanni Cammarota, Maurizio Pompili, Antonio Gasbarrini, Francesca Romana Ponziani. Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives. Journal of Clinical Medicine 2021; 10(12): 2605 doi: 10.3390/jcm10122605
|
| 12 |
Xin Feng, Xiaoqing Li, Xin Zhang, Weiqing Chen, Yin Tian, Qingqing Yang, Yingying Yang, Hui Pan, Zheng Jiang, Stefania Cantore. Hepatic Encephalopathy in Cirrhotic Patients and Risk of Small Intestinal Bacterial Overgrowth: A Systematic Review and Meta-Analysis. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/2469513
|
| 13 |
Irina Efremova, Roman Maslennikov, Elena Poluektova, Maria Zharkova, Anna Kudryavtseva, George Krasnov, Maria Fedorova, Elena Shirokova, Evgenii Kozlov, Anna Levshina, Vladimir Ivashkin. Gut Dysbiosis and Hemodynamic Changes as Links of the Pathogenesis of Complications of Cirrhosis. Microorganisms 2023; 11(9): 2202 doi: 10.3390/microorganisms11092202
|
| 14 |
Hiroshi Fukui. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms 2015; 3(4): 759 doi: 10.3390/microorganisms3040759
|
| 15 |
Tawfik Khoury, Keren Tzukert, Roy Abel, Ayman Abu Rmeileh, Ronen Levi, Yaron Ilan. The gut‐kidney axis in chronic renal failure: A new potential target for therapy. Hemodialysis International 2017; 21(3): 323 doi: 10.1111/hdi.12486
|
| 16 |
Hiroshi Fukui. Leaky Gut and Gut-Liver Axis in Liver Cirrhosis: Clinical Studies Update. Gut and Liver 2021; 15(5): 666 doi: 10.5009/gnl20032
|
| 17 |
Tanya Ralli, Yub Raj Neupane, Zoya Saifi, Kanchan Kohli. Gut Microbiota as an Emerging Therapeutic Avenue for the Treatment of Nonalcoholic Fatty Liver Disease. Current Pharmaceutical Design 2021; 27(46): 4677 doi: 10.2174/1389201022666210625141526
|
| 18 |
Tanya Ralli, Zoya Saifi, Neha Tyagi, Arya Vidyadhari, Vidhu Aeri, Kanchan Kohli. Deciphering the role of gut metabolites in non-alcoholic fatty liver disease. Critical Reviews in Microbiology 2023; 49(6): 815 doi: 10.1080/1040841X.2022.2142091
|
| 19 |
Takeshi Kitai, W.H. Wilson Tang. Gut microbiota in cardiovascular disease and heart failure. Clinical Science 2018; 132(1): 85 doi: 10.1042/CS20171090
|
| 20 |
Adrian Boicean, Victoria Birlutiu, Cristian Ichim, Olga Brusnic, Danusia Maria Onișor. Fecal Microbiota Transplantation in Liver Cirrhosis. Biomedicines 2023; 11(11): 2930 doi: 10.3390/biomedicines11112930
|
| 21 |
Gursimran Kochhar, Tavankit Singh, Henry Dust, Rocio Lopez, Arthur J. McCullough, Xiuli Liu, John Fung, Bo Shen. Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation. Inflammatory Bowel Diseases 2016; 22(7): 1670 doi: 10.1097/MIB.0000000000000830
|
| 22 |
Elina Manzhalii, Valentyna Moyseyenko, Vitalii Kondratiuk, Nataliia Molochek, Tetyana Falalyeyeva, Nazarii Kobyliak. Effect of a specific <i>Escherichia coli Nissle 1917</i> strain on minimal/mild hepatic encephalopathy treatment. World Journal of Hepatology 2022; 14(3): 634-646 doi: 10.4254/wjh.v14.i3.634
|
| 23 |
Nadir Abbas, Neil Rajoriya, Ahmed M Elsharkawy, Abhishek Chauhan. Acute-on-chronic liver failure (ACLF) in 2022: have novel treatment paradigms already arrived?. Expert Review of Gastroenterology & Hepatology 2022; 16(7): 639 doi: 10.1080/17474124.2022.2097070
|
| 24 |
Roman Maslennikov, Vladimir Ivashkin, Irina Efremova, Elena Poluektova, Elena Shirokova. Gut-liver axis in cirrhosis: Are hemodynamic changes a missing link?. World Journal of Clinical Cases 2021; 9(31): 9320-9332 doi: 10.12998/wjcc.v9.i31.9320
|
| 25 |
Rodney Dietert, Janice Dietert. The Microbiome and Sustainable Healthcare. Healthcare 2015; 3(1): 100 doi: 10.3390/healthcare3010100
|
| 26 |
Hiroshi Fukui, Reiner Wiest. Changes of Intestinal Functions in Liver Cirrhosis. Inflammatory Intestinal Diseases 2016; 1(1): 24 doi: 10.1159/000444436
|
| 27 |
Tim Hendrikx, Bernd Schnabl. Antimicrobial proteins: intestinal guards to protect against liver disease. Journal of Gastroenterology 2019; 54(3): 209 doi: 10.1007/s00535-018-1521-8
|
| 28 |
Ting‐Chin David Shen, Nikolaos Pyrsopoulos, Vinod K. Rustgi. Microbiota and the liver. Liver Transplantation 2018; 24(4): 539 doi: 10.1002/lt.25008
|
| 29 |
Damian Piotrowski, Anna Boroń-Kaczmarska. Bacterial infections and hepatic encephalopathy in liver cirrhosis–prophylaxis and treatment. Advances in Medical Sciences 2017; 62(2): 345 doi: 10.1016/j.advms.2016.11.009
|
| 30 |
Radmila V Karpova, Ksenia S Russkova, Yuliya N Lavrentieva. <p>Increases in Autoantibody Level Associated with Degenerative Changes in the Intestinal Mucosa in Liver Cirrhosis</p>. Clinical and Experimental Gastroenterology 2020; : 315 doi: 10.2147/CEG.S263176
|
| 31 |
Francesca Fianchi, Antonio Liguori, Antonio Gasbarrini, Antonio Grieco, Luca Miele. Nonalcoholic Fatty Liver Disease (NAFLD) as Model of Gut–Liver Axis Interaction: From Pathophysiology to Potential Target of Treatment for Personalized Therapy. International Journal of Molecular Sciences 2021; 22(12): 6485 doi: 10.3390/ijms22126485
|
| 32 |
Mamatha Bhat, Bianca M Arendt, Venkat Bhat, Eberhard L Renner, Atul Humar, Johane P Allard. Implication of the intestinal microbiome in complications of cirrhosis. World Journal of Hepatology 2016; 8(27): 1128-1136 doi: 10.4254/wjh.v8.i27.1128
|
| 33 |
Mikio Kajihara, Shigeo Koido, Tomoya Kanai, Zensho Ito, Yoshihiro Matsumoto, Kazuki Takakura, Masayuki Saruta, Kumiko Kato, Toshitaka Odamaki, Jin-zhong Xiao, Nobuhiro Sato, Toshifumi Ohkusa. Characterisation of blood microbiota in patients with liver cirrhosis. European Journal of Gastroenterology & Hepatology 2019; 31(12): 1577 doi: 10.1097/MEG.0000000000001494
|
| 34 |
Xueying Wang, Min Ding, Weiwei Wang, Xiaojie Zheng, Cyriac Abby Philips, Nahum Méndez-Sánchez, Hongxu Jin, Xingshun Qi. Association Between Bowel Wall Thickening and Long-Term Outcomes in Decompensated Liver Cirrhosis. Advances in Therapy 2024; 41(6): 2217 doi: 10.1007/s12325-023-02690-z
|
| 35 |
Rohan Dalal, Richard G McGee, Stephen M Riordan, Angela C Webster. Probiotics for people with hepatic encephalopathy. Cochrane Database of Systematic Reviews 2017; 2021(1) doi: 10.1002/14651858.CD008716.pub3
|
| 36 |
Matthew R. Panasevich, E. M. Morris, S. V. Chintapalli, U. D. Wankhade, K. Shankar, S. L. Britton, L. G. Koch, J. P. Thyfault, R. S. Rector. Gut microbiota are linked to increased susceptibility to hepatic steatosis in low-aerobic-capacity rats fed an acute high-fat diet. American Journal of Physiology-Gastrointestinal and Liver Physiology 2016; 311(1): G166 doi: 10.1152/ajpgi.00065.2016
|
| 37 |
Ciara E. Keogh, Danielle H.J. Kim, Matteo M. Pusceddu, Trina A. Knotts, Gonzalo Rabasa, Jessica A. Sladek, Michael T. Hsieh, Mackenzie Honeycutt, Ingrid Brust-Mascher, Mariana Barboza, Mélanie G. Gareau. Myelin as a regulator of development of the microbiota-gut-brain axis. Brain, Behavior, and Immunity 2021; 91: 437 doi: 10.1016/j.bbi.2020.11.001
|
| 38 |
Mohd Talha Noor, Piyush Manoria. Immune Dysfunction in Cirrhosis. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2016.00056
|
| 39 |
Roman Maslennikov, Irina Efremova, Vladimir Ivashkin, Maria Zharkova, Elena Poluektova, Elena Shirokova, Konstantin Ivashkin. Effect of probiotics on hemodynamic changes and complications associated with cirrhosis: A pilot randomized controlled trial. World Journal of Hepatology 2022; 14(8): 1667-1677 doi: 10.4254/wjh.v14.i8.1667
|
| 40 |
Jinjian Huang, Jianan Ren, Luise Brakert, Jiao Jiao, Qinjie Liu, Gefei Wang, Xiuwen Wu, Steven W.M. Olde Damink. A New Scoring System to Predict Blood Stream Infections in Patients with Complicated Intra-Abdominal Infections: Experience from a Tertiary Referral Hospital in China. Surgical Infections 2018; 19(4): 459 doi: 10.1089/sur.2017.243
|